Voxcan has a number of core facilities providing quality services tailored to meet our customers needs and goals. To support the development and accelerate the time to market of your antitumoral molecules, vaccines and implants, Voxcan can rely on the highly qualified scientist team and on the wide range of technologies used to perform in-vitro and in-vivo analysis.

In addition, your studies can be performed into a Biosafety Level 2 and Biosafety Level 3 environment compliant with the world most stringent rules of security and confinement.

Furthermore all our preclinical studies are carried out in a quality context strictly following the GLP Guidelines edicted by OECD providing you with ALCOA raw data.